Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>The September 2025 index review results for F100 and F250 indices were announced yesterday after LSE market close.</li>
<li>There will be two ADDs and two DELS for the F100 index. Separately, there will be five ADDs and six DELs for the F250 index.</li>
<li>As a consequence of new transfers and the relaxation of trading currency requirements, some F100 and F250 ADDs will also be added to the F-All Share index simultaneously.</li>
</ul>


The September 2025 index review results for F100 and F250 indices were announced yesterday after LSE market close.
There will be two ADDs and two DELS for the F100 index. Separately, there will be five ADDs and six DELs for the F250 index.
As a consequence of new transfers and the relaxation of trading currency requirements, some F100 and F250 ADDs will also be added to the F-All Share index simultaneously.


Quiddity Leaderboard F100/F250 Sep25: 14/15 Expected ADDs/DELs Correct; Intra-Review ADDs Next!

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.</li>
<li>Our latest estimates suggest there could be two regular changes for F100 and six regular changes for F250 during the September 2025 rebalance.</li>
<li>After that, we expect multiple M&amp;A-related intra-review changes over the next few weeks.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.
Our latest estimates suggest there could be two regular changes for F100 and six regular changes for F250 during the September 2025 rebalance.
After that, we expect multiple M&amp;A-related intra-review changes over the next few weeks.


Quiddity Leaderboard F100/F250 Sep25: ~10 Regular & Intra-Review Changes Likely in September

US-EU Index Rebalances / Quantitative Researcher

Dimitris Ioannidis

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/mytilineos-holdings-sa" target="_blank" data-smartkarma-citation="entities:25114:1" rel="noopener">Mytilineos Holdings Sa (MYTIL GA)</a> is projected to be added to F100 following its change of incorporation and primary listing from Greece to UK.</li>
<li>A methodology change in currency trading requirements is expected to result in <a href="https://www.smartkarma.com/entities/princess-private-equity-holdin" target="_blank" data-smartkarma-citation="entities:22083:1" rel="noopener">Partners Group Private Equity (PEY LN)</a> and <a href="https://www.smartkarma.com/entities/biopharma-credit-plc-fund" target="_blank" data-smartkarma-citation="entities:28317:1" rel="noopener">BioPharma Credit PLC (BPCR LN)</a> entering F250.</li>
<li>
<a href="https://www.smartkarma.com/entities/oakley-capital-investments-limited" target="_blank" data-smartkarma-citation="entities:23334:1" rel="noopener">Oakley Capital Investments (OCI LN)</a> is expected to be included in F250 following its listing transfer from AIM to the Main market of the LSE.</li>
</ul>



Mytilineos Holdings Sa (MYTIL GA) is projected to be added to F100 following its change of incorporation and primary listing from Greece to UK.
A methodology change in currency trading requirements is expected to result in Partners Group Private Equity (PEY LN) and BioPharma Credit PLC (BPCR LN) entering F250.

Oakley Capital Investments (OCI LN) is expected to be included in F250 following its listing transfer from AIM to the Main market of the LSE.


UK Index September 2025 Forecast: Greece in F100 & Other New Candidates in F250

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.</li>
<li>We see two M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review and then at least four more before the end of the year.</li>
<li>Separately, our latest estimates suggest there could be one regular change for the F100 index and one regular change for F250 during the September 2025 rebalance.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.
We see two M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review and then at least four more before the end of the year.
Separately, our latest estimates suggest there could be one regular change for the F100 index and one regular change for F250 during the September 2025 rebalance.


Quiddity Leaderboard F100/F250 Sep25: High-Impact ADD Due to Rule Change + More Intra-Review Changes

<ul>
<li>In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.</li>
<li>We see three M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review <strong><em>(one announced later today)</em></strong> and then two more shortly after the rebal event. </li>
<li>Our latest estimates suggest there could be one regular change for the F250 index during the September 2025 rebalance. We do not currently see any changes for the F100.</li>
</ul>


In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the September 2025 index rebal event.
We see three M&amp;A-related intra-review changes for the F250 index prior to the September 2025 review (one announced later today) and then two more shortly after the rebal event. 
Our latest estimates suggest there could be one regular change for the F250 index during the September 2025 rebalance. We do not currently see any changes for the F100.


Quiddity Leaderboard F100/F250 Sep25 Results: Methodology Change Could Result in a Surprise Addition

United Kingdom

BioPharma Credit is a UK-based closed-ended investment company that specializes in providing debt capital to the life sciences industry. The company invests in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. It aims to generate long-term shareholder returns, primarily through sustainable income distributions. Headquartered in London, United Kingdom, the company was founded in 2016.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

BioPharma Credit (BPCR LN)

Quiddity Leaderboard F100/F250 Sep25: 14/15 Expected ADDs/DELs Correct; Intra-Review ADDs Next!

We got 14/15 expected ADDs/DELs correct. The only surprise was Bloomsbury getting deleted from F250 instead of Ocean Wilson.

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25: ~10 Regular & Intra-Review Changes Likely in September

F100/250 Sep25 index changes will be confirmed after market close today. Yesterday was the base date for final ranks. Please see discussion point...

Janaghan Jeyakumar, CFA

UK Index September 2025 Forecast: Greece in F100 & Other New Candidates in F250

MYTIL is projected to join UK's F100 after changing incorporation and primary listing from Greece to UK; PEY and BPCR are expected to enter F250...

Dimitris Ioannidis

Quiddity Leaderboard F100/F250 Sep25: High-Impact ADD Due to Rule Change + More Intra-Review Changes

BioPharma Credit PLC Fund (BPCR LN) has been our top F250 potential ADD after a recent rule change. This could be a high-impact index addition that...

Janaghan Jeyakumar, CFA

Quiddity Leaderboard F100/F250 Sep25 Results: Methodology Change Could Result in a Surprise Addition

We see many high-impact F250 potential ADDs with opportunities to get added to the index during the regular Sep25 index review or on an intra...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)